PHM 835 - Biopharmaceuticals: From Development to Manufacturing*
Biopharmaceutical development and manufacturing processes for recombinant proteins, monoclonal antibodies, vaccines and cell-based therapeutics (stem cells). Emphasis on real-world case studies and group projects.
- Developing biopharmaceuticals
- Pharmacological principles of biopharmaceuticals
- Cell-based therapies - recombinant proteins and antibodies, vaccines, cellular therapeutics, gene therapy
- Manufacturing strategies
- Real-world considerations for development and manufacture of biologic therapeutics:
- Safe manufacture of biologics
- New product development and manufacturing strategies
- Therapeutic applications of biopharma- ceutical drug products
Open to MSU graduate students enrolled in majors within biomedical disciplines.
Manufacturing of Pharmaceutical Proteins
Dr. Tobi Limke Received her PhD in Pharmacology & Toxicology-Environmental Toxicology from Michigan State University. She also holds an MBA from the University of Maryland. She was a Postdoctoral Fellow at the National Institute on Aging at the National Institutes of Health in Baltimore, MD. Dr. Limke has experience working with classic pharmaceutical and biotechnology companies in both scientific and business roles. Currently, she works as a freelance technical marketing consultant for the biopharmaceutical industry.a career-long research interest in the central neural control of cardiorespiratory function.
- MS/Pharmacology & Toxicology
- MS/Integrative Pharmacology
- Grad Cert/SafetyPhm
- 730 MSU students
- 731 Lifelong In-State
- 732 Lifelong Out-State